Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

PURPOSE: To determine the cost effectiveness of intraperitoneal versus intravenous regimens for adjuvant treatment of optimally resected stage III ovarian cancer. PATIENTS AND METHODS: A decision model was developed to compare the cost effectiveness at 7-, 11.5-, and 35-year horizons of intravenous...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., Armstrong, Deborah K., Kulasingam, Shalini
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2008
Sujets:
Gynecologic Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654369/
https://ncbi.nlm.nih.gov/pubmed/18757328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.1961
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires